Cosmetic composition for skin whitening comprising senkyunolide a as active ingredient
Abstract
The present invention relates to cosmetic compositions and more particularly to skin-whitening cosmetic compositions comprising senkyunolide A as an active ingredient. The present invention discloses the novel inhibitory function of senkyunolide A isolated from Cnidium officinale and Ligusticum chuanxiong on the melanocyte-stimulating hormone (MSH), and provides MSH-inhibitory compositions and skin-whitening cosmetic compositions comprising the senkyunolide A. The compositions of the present invention show significantly enhanced skin-whitening effect owing to its efficient inhibition of MSH even in lower concentration.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A cosmetic composition for skin whitening comprising:
(a) a senkyunolide A as an active ingredient; and (b) a cosmetically acceptable carrier.
2 . A composition for inhibiting melanocyte-stimulating hormone (MSH) comprising senkyunolide A as an active ingredient.
3 . The composition according to claim 1 or 2 , wherein the senkyunolide A is purified from Cnidium officinale and Ligusticum chuanxiong.
4 . The composition according to claim 1 or 2 , wherein the senkyunolide A is chemically synthesized.
5 . The cosmetic composition according to claim 1 , wherein the senkyunolide A is present in an amount of 0.00001-20 wt % based on the total weight of the composition.
6 . The cosmetic composition according to claim 1 , wherein the composition is in the form of one selected from a solution, a suspension, an emulsion, a paste, an ointment, a gel, a cream, a lotion, a powder, a soap, a surfactant-containing cleanser, an oil, a powder foundation, an emulsion foundation, a wax foundation and a sprayJoin the waitlist — get patent alerts
Track US2004081631A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.